大行評級|里昂:上調金山雲目標價至5.5美元 第三季業績受公有云表現強勁及企業雲回升所帶動
里昂發表報吿指,金山雲第三季業績大致符合預期,總收入按年上升16%,主要受公有云表現強勁及企業雲回升所帶動;經調整EBITDA利潤率進一步上升至9.8 %。公司與小米及金山軟件續訂框架協議,合作關係更緊密,交易收入及融資上限提高成為亮點。同時關注小米自動駕駛帶來的收入上升空間。
里昂預期金山雲第四季的營收按年增長將加速至18%,而經調整EBITDA利潤率料將進一步改善至13%。該行調高2024和2025財政年度營收預測各1%和6%,上調經調整淨利預測6400萬和1億元,以反映強勁的AI業務增長。該行將目標價由3美元上調至5.5美元,維持“跑贏大市”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.